EUVIMEDEUVIMED entdecken
Open Access

In vivo editing of lung stem cells for durable gene correction in mice

Yehui Sun iD, Sumanta Chatterjee iD, Xizhen Lian, Zachary Traylor, Sandhya R Sattiraju iD, Yufen Xiao iD, Sean A Dilliard, Yun-Chieh Sung iD, Minjeong Kim, Sang M Lee iD, Stephen Moore iD, Xu Wang und 18 weitere

Science · 14.06.2024 · 384 (6701) · 1196-1202

DOI: 10.1126/science.adk9428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science, erschienen am 14.06.2024. Verfasst von Yehui Sun und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, The Unive…. Hauptthemen laut MEDLINE: Cystic Fibrosis, Cystic Fibrosis Transmembrane Conductance Regulator, Gene Editing, Liposomes. Die Arbeit wurde bisher 201-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NIBIB NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In vivo genome correction holds promise for generating durable disease cures; yet, effective stem cell editing remains challenging. In this work, we demonstrate that optimized lung-targeting lipid nanoparticles (LNPs) enable high levels of genome editing in stem cells, yielding durable responses. Intravenously administered gene-editing LNPs in activatable tdTomato mice achieved >70% lung stem cell editing, sustaining tdTomato expression in >80% of lung epithelial cells for 660 days. Addressing cystic fibrosis (CF), NG-ABE8e messenger RNA (mRNA)–sgR553X LNPs mediated >95% cystic fibrosis transmembrane conductance regulator (CFTR) DNA correction, restored CFTR function in primary patient-derived bronchial epithelial cells equivalent to Trikafta for F508del, corrected intestinal organoids and corrected R553X nonsense mutations in 50% of lung stem cells in CF mice. These findings introduce LNP-enabled tissue stem cell editing for disease-modifying genome correction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cystic FibrosisCystic Fibrosis Transmembrane Conductance RegulatorGene EditingLiposomesLungNanoparticlesStem CellsAnimalsHumansMiceCRISPR-Cas SystemsEpithelial CellsGenetic TherapyOrganoids

Substanzen

CFTR protein, humanCystic Fibrosis Transmembrane Conductance RegulatorLipid NanoparticlesLiposomes

Autor:innen und Institutionen

  • Department of Biomedical Engineering, Department of Biochemistry, Simmons Comprehensive Cancer Center, Program in Genetic Drug Engineering, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
  • Department of Genetics and Genome Sciences, Case Western Reserve University School of Medicine, Cleveland, OH 44106, USA.
  • ReCode Therapeutics, Menlo Park, CA 94025, USA.
  • Department of Internal Medicine, The University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.

ORCID-Profile: Yehui Sun, Sumanta Chatterjee, Sandhya R Sattiraju, Yufen Xiao, Yun-Chieh Sung, Sang M Lee, Stephen Moore, Di Zhang, Shiying Wu, Pratima Basak, Jialu Wang, Rachel J Mann, David F LePage, Weihong Jiang, Mirko Hennig, Anna Martinez, Mitchell L Drumm, Craig A Hodges, Daniel J Siegwart

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS

Zitieren

APA

Sun, Y., Chatterjee, S., Lian, X., Traylor, Z., Sattiraju, S. R., Xiao, Y., Dilliard, S. A., Sung, Y. C., Kim, M., Lee, S. M., Moore, S., Wang, X., Zhang, D., Wu, S., Basak, P., Wang, J., Liu, J., Mann, R. J., LePage, D. F., …, & Siegwart, D. J. (2024). In vivo editing of lung stem cells for durable gene correction in mice. Science, 384(6701), 1196-1202. https://doi.org/10.1126/science.adk9428

Vancouver

Sun Y, Chatterjee S, Lian X, Traylor Z, Sattiraju SR, Xiao Y, et al. In vivo editing of lung stem cells for durable gene correction in mice. Science. 2024;384(6701):1196-1202. doi:10.1126/science.adk9428

BibTeX
@article{Sun2024,
  author = {Sun, Yehui and Chatterjee, Sumanta and Lian, Xizhen and Traylor, Zachary and Sattiraju, Sandhya R and Xiao, Yufen and Dilliard, Sean A and Sung, Yun-Chieh and Kim, Minjeong and Lee, Sang M and Moore, Stephen and Wang, Xu and Zhang, Di and Wu, Shiying and Basak, Pratima and Wang, Jialu and Liu, Jing and Mann, Rachel J and LePage, David F and Jiang, Weihong and Abid, Shadaan and Hennig, Mirko and Martinez, Anna and Wustman, Brandon A and Lockhart, David J and Jain, Raksha and Conlon, Ronald A and Drumm, Mitchell L and Hodges, Craig A and Siegwart, Daniel J},
  title = {In vivo editing of lung stem cells for durable gene correction in mice},
  journal = {Science},
  year = {2024},
  volume = {384},
  number = {6701},
  pages = {1196--1202},
  doi = {10.1126/science.adk9428}
}
Kostenlos starten →